BMT Calsis is a Turkey-based startup that has positioned itself as a pioneer in creating advanced orthobiologic materials. Founded in 2008, the company is committed to the development and commercialization of orthobiologic materials. With a focus on Biotechnology, Deep Tech, and Life Sciences, BMT Calsis aims to enhance the quality of life for patients by supplying health professionals with cutting-edge orthobiologic products. While details regarding the last investment and investors are currently unavailable, the company's dedication to leveraging technology to advance healthcare makes it a promising candidate for investment. As BMT Calsis continues to make strides in the orthobiologics space, it presents an intriguing opportunity for venture capitalists looking to support innovative solutions in the healthcare industry.
There is no investment information
No recent news or press coverage available for BMT Calsis.